滬深市場個股詳情
301331 恩威醫葯
- 26.50
- +0.84+3.27%
已收盤 12/12 15:00 (北京)
27.27億總市值77.03市盈率TTM
27.33最高價25.54最低價3.19萬手成交量25.66今開25.66昨收8435.25萬成交額9.63%換手率31.59市盈率(靜)1.03億總股本32.5052周最高2.67市淨率8.77億流通值18.5252周最低30.79漲停價3310.17萬流通股39.28歷史最高20.53跌停價6.98%振幅18.52歷史最低0.55股息TTM26.46平均價1.45萬手內盤2.06%股息率TTM100股每手1.43萬手外盤
恩威醫葯關鍵統計數據
全部
顯示同比
| (Q9)2024/09/30 | (Q6)2024/06/30 | (Q3)2024/03/31 | (FY)2023/12/31 | (Q9)2023/09/30 | (Q6)2023/06/30 | (Q3)2023/03/31 | (FY)2022/12/31 | (Q9)2022/09/30 | (Q6)2022/06/30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 營業總收入 | -1.67%5.6億 | -1.80%3.88億 | -8.63%1.83億 | 13.54%7.85億 | 17.93%5.7億 | 18.06%3.95億 | 27.41%2.01億 | 1.75%6.92億 | -0.72%4.83億 | 0.47%3.35億 |
| 營業收入 | -1.67%5.6億 | -1.80%3.88億 | -8.63%1.83億 | 13.54%7.85億 | 17.93%5.7億 | 18.06%3.95億 | 27.41%2.01億 | 1.75%6.92億 | -0.72%4.83億 | 0.47%3.35億 |
| 其他業務收入 | ---- | 25.91%239.76萬 | ---- | -2.09%398.74萬 | ---- | -2.51%190.42萬 | ---- | 4.15%407.25萬 | ---- | -1.51%195.32萬 |
| 營業總成本 | 7.54%5.35億 | 9.97%3.66億 | 3.55%1.74億 | 12.55%6.98億 | 14.45%4.97億 | 14.17%3.32億 | 25.43%1.68億 | 6.92%6.2億 | 4.64%4.35億 | 4.05%2.91億 |
| 營業成本 | -2.39%2.75億 | -2.98%1.87億 | -3.07%9,126萬 | 11.12%3.83億 | 13.72%2.82億 | 18.57%1.93億 | 24.78%9,415.32萬 | 16.07%3.44億 | 14.14%2.48億 | 13.28%1.62億 |
| 營業稅金及附加 | 24.30%944.7萬 | 22.31%646.61萬 | -8.12%254萬 | 10.15%1,089.28萬 | -13.30%760.02萬 | -12.03%528.65萬 | 1.75%276.45萬 | -15.06%988.93萬 | 14.87%876.61萬 | 21.72%600.94萬 |
| 銷售費用 | 17.78%1.88億 | 26.11%1.32億 | 3.18%6,089.86萬 | 17.13%2.35億 | 18.09%1.59億 | 9.52%1.05億 | 36.32%5,901.95萬 | -4.45%2.01億 | -7.58%1.35億 | -5.33%9,563萬 |
| 管理費用 | 47.97%5,812.67萬 | 46.11%3,726.17萬 | 52.36%1,820.83萬 | -0.07%5,943.42萬 | 0.17%3,928.27萬 | 0.77%2,550.19萬 | 2.37%1,195.12萬 | 4.30%5,947.73萬 | -4.82%3,921.69萬 | -8.99%2,530.69萬 |
| 財務費用 | 81.17%-101.67萬 | 90.05%-36.39萬 | 78.31%-40.7萬 | -378.82%-641.09萬 | -1,213.46%-540.02萬 | -2,594.75%-365.82萬 | -4,471.44%-187.61萬 | -282.31%-133.89萬 | -238.93%-41.11萬 | -122.48%-13.58萬 |
| -利息費用 | --147.62萬 | --56.88萬 | --14.44萬 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -利息收入 | 48.78%-283.16萬 | 67.17%-123.61萬 | 69.51%-59.04萬 | -369.46%-656.18萬 | -1,225.58%-552.79萬 | -1,876.26%-376.52萬 | -2,369.01%-193.63萬 | -169.67%-139.77萬 | 5.02%-41.7萬 | 37.46%-19.05萬 |
| 研發費用 | -61.44%577.07萬 | -58.26%336.78萬 | -23.99%161.72萬 | 123.71%1,681.61萬 | 234.70%1,496.63萬 | 301.95%806.77萬 | 124.73%212.77萬 | 73.81%751.7萬 | 38.85%447.16萬 | -6.50%200.72萬 |
| 信用減值損失 | 67.89%-51.19萬 | -38.66%-168.17萬 | 43.86%-38.32萬 | 76.09%-40.34萬 | 20.42%-159.43萬 | 18.02%-121.28萬 | 10.40%-68.25萬 | -481.64%-168.66萬 | -78.50%-200.34萬 | -41.66%-147.93萬 |
| 資產減值損失 | -1,214.28%-122.56萬 | -5,207.93%-117.91萬 | -1,266.18%-53.8萬 | -577.81%-17.95萬 | 323.83%11萬 | 93.52%-2.22萬 | 81.92%-3.94萬 | -83.52%3.76萬 | 91.48%-4.91萬 | -23.50%-34.27萬 |
| 非經營性淨收益 | -75.24%306.2萬 | -92.80%80.86萬 | -23.26%113.37萬 | 37.56%1,486.06萬 | 44.63%1,236.53萬 | 1,632.24%1,122.34萬 | 446.23%147.72萬 | -45.42%1,080.27萬 | 19.76%854.97萬 | 410.56%64.79萬 |
| 投資淨收益 | -16.57%240.04萬 | -10.22%184.89萬 | -0.81%105.72萬 | 533.90%374.3萬 | 2,876.66%287.72萬 | 2,500.71%205.93萬 | --106.59萬 | 235.55%59.05萬 | 79.17%-10.36萬 | 82.28%-8.58萬 |
| -其中:對聯營合營企業的投資收益 | -476.97%-4.35萬 | 50.58%6,016.68 | ---- | 132.79%2.18萬 | 111.15%1.16萬 | 104.66%3,995.8 | ---- | 84.71%-6.66萬 | 79.17%-10.36萬 | 82.28%-8.58萬 |
| 資產處置收益 | -304.75%-16.68萬 | -195.90%-12.19萬 | -90.68%-7.86萬 | ---4.1萬 | ---4.12萬 | ---4.12萬 | ---4.12萬 | --0 | ---- | --0 |
| 其他收益 | -76.70%256.59萬 | -81.39%194.25萬 | -8.36%107.62萬 | -1.01%1,174.14萬 | 2.87%1,101.36萬 | 308.51%1,044.03萬 | 112.44%117.44萬 | -41.54%1,186.13萬 | 14.68%1,070.59萬 | 32.22%255.57萬 |
| 營業利潤 | -66.38%2,853.33萬 | -68.45%2,334.91萬 | -69.26%1,049.26萬 | 24.22%1.02億 | 48.37%8,487.37萬 | 67.31%7,400.04萬 | 47.60%3,413.74萬 | -31.28%8,189.57萬 | -27.19%5,720.49萬 | -17.31%4,422.92萬 |
| 加:營業外收入 | -23.45%21.17萬 | -39.24%6,121.2 | --0 | -30.42%28.45萬 | -30.91%27.65萬 | -97.48%1.01萬 | -64.33%1.01萬 | 1,720.51%40.89萬 | 1,682.17%40.02萬 | 1,682.17%40.02萬 |
| 減:營業外支出 | 17,231.71%322.24萬 | 2,207.22%41.74萬 | --571.95 | 57.54%69.66萬 | -95.65%1.86萬 | 289.36%1.81萬 | --0 | 496.08%44.22萬 | 495.25%42.77萬 | -84.34%4,645.89 |
| 利潤總額 | -70.02%2,552.26萬 | -69.00%2,293.79萬 | -69.27%1,049.2萬 | 23.76%1.01億 | 48.89%8,513.16萬 | 65.81%7,399.24萬 | 47.47%3,414.75萬 | -31.28%8,186.24萬 | -27.18%5,717.75萬 | -16.56%4,462.48萬 |
| 減:所得稅費用 | -71.30%350.06萬 | -50.12%500.34萬 | -68.08%206.81萬 | 6.69%1,500.25萬 | 57.88%1,219.66萬 | 84.46%1,003.03萬 | 123.60%647.79萬 | -19.16%1,406.11萬 | -40.72%772.51萬 | -39.59%543.76萬 |
| 淨利潤 | -69.81%2,202.2萬 | -71.96%1,793.44萬 | -69.56%842.39萬 | 27.30%8,631.23萬 | 47.49%7,293.5萬 | 63.22%6,396.2萬 | 36.58%2,766.96萬 | -33.35%6,780.13萬 | -24.48%4,945.24萬 | -11.91%3,918.71萬 |
| 持續經營淨利潤 | -69.81%2,202.2萬 | -71.96%1,793.44萬 | -69.56%842.39萬 | 27.30%8,631.23萬 | 47.49%7,293.5萬 | 63.22%6,396.2萬 | 36.58%2,766.96萬 | -33.35%6,780.13萬 | -24.48%4,945.24萬 | -11.91%3,918.71萬 |
| 歸屬于母公司所有者的淨利潤 | -69.81%2,202.2萬 | -71.96%1,793.44萬 | -69.56%842.39萬 | 27.30%8,631.23萬 | 47.49%7,293.5萬 | 63.22%6,396.2萬 | 36.58%2,766.96萬 | -33.35%6,780.13萬 | -24.48%4,945.24萬 | -11.91%3,918.71萬 |
| 每股收益 | ||||||||||
| 基本每股收益 | -69.21%0.2183 | -71.54%0.1769 | -69.07%0.122 | 3.52%1.2317 | -24.60%0.7089 | -16.56%0.6216 | 2.44%0.3945 | -38.49%1.1898 | -24.48%0.9402 | -11.89%0.745 |
| 稀釋每股收益 | -69.40%0.2169 | -71.69%0.176 | -69.10%0.1219 | 3.50%1.2315 | -24.60%0.7089 | -16.56%0.6216 | 2.44%0.3945 | -38.49%1.1898 | -24.48%0.9402 | -11.89%0.745 |
| 其他綜合收益 | ||||||||||
| 綜合收益總額 | -69.81%2,202.2萬 | -71.96%1,793.44萬 | -69.56%842.39萬 | 27.30%8,631.23萬 | 47.49%7,293.5萬 | 63.22%6,396.2萬 | 36.58%2,766.96萬 | -33.35%6,780.13萬 | -24.48%4,945.24萬 | -11.91%3,918.71萬 |
| 歸屬于母公司所有者的綜合收益總額 | -69.81%2,202.2萬 | -71.96%1,793.44萬 | -69.56%842.39萬 | 27.30%8,631.23萬 | 47.49%7,293.5萬 | 63.22%6,396.2萬 | 36.58%2,766.96萬 | -33.35%6,780.13萬 | -24.48%4,945.24萬 | -11.91%3,918.71萬 |
| 貨幣單位 | 人民幣 | 人民幣 | 人民幣 | 人民幣 | 人民幣 | 人民幣 | 人民幣 | 人民幣 | 人民幣 | 人民幣 |
| 會計準則 | 新會計準則(2007) | 新會計準則(2007) | 新會計準則(2007) | 新會計準則(2007) | 新會計準則(2007) | 新會計準則(2007) | 新會計準則(2007) | 新會計準則(2007) | 新會計準則(2007) | 新會計準則(2007) |
| 審計意見 | -- | -- | -- | 無保留意見 | -- | -- | -- | 無保留意見 | -- | -- |
| 會計師事務所 | -- | -- | -- | 信永中和會計師事務所(特殊普通合夥) | -- | -- | -- | 信永中和會計師事務所(特殊普通合夥) | -- | -- |
FY：Financial Year 年度報告，相當於上市公司向SEC披露的10-K文件。
Q：Quarter 季度報告，相當於上市公司向SEC披露的10-Q文件，其中Q1、Q2、Q3、Q4為單季報，跨度為3個月；Q6、Q9為累計季報，Q6為6個月，Q9為9個月。
熱議
滬深
綜合熱度
股票代碼
最新價
升跌幅
暫無數據
